Yıl: 2021 Cilt: 58 Sayı: 3 Sayfa Aralığı: 171 - 175 Metin Dili: Türkçe DOI: 10.29399/npa.27407 İndeks Tarihi: 29-09-2021

Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması

Öz:
Amaç: Otizm spektrum bozukluğu genetik ve fenotipik olarak heterojenbir gruptur. Bugüne kadar yapılan genetik araştırmalar, bu hastalığınetiyolojisinde hem yaygın hem de nadir genetik varyantların roloynadığını ileri sürmüştür. Çalışmamızda FOXP2, GRIN2B, KATNAL2 veGABRA4 genlerinin otizm spektrum bozukluğunun patogenezindekirolünü araştırmayı amaçladık.Yöntem: Prospektif olarak planlanan çalışmamızda, otizm spektrumbozukluğu tanısı alan 96 hastada FOXP2, GRIN2B, KATNAL2 ve GABRA4genlerinin tüm ekzonları, ekzon-intron bileşke bölgeleri, yeni nesil dizianalizi yöntemi ile dizilendi.Bulgular: Çalışmamızda ortalama yaş 10.1 ve erkek/kadın oranı 75/21idi. FOXP2, GRIN2B, KATNAL2 ve GABRA4 genlerinde patojenik, olasıpatojenik varyantlar saptanmazken, 50 olguda (%52) klinik önemibilinmeyen 69 intronik varyant tespit edildi. Bunlar arasında 26’sıGABRA4 geninde, 22’si FOXP2 geninde, 13’ü KATNAL2 geninde ve 8’iGRIN2B genindeydi. Bu 69 varyantın yirmi üçü, daha önce literatürderapor edilmeyen, novel varyantlardı.Sonuç: Çalışmamızda, otizm spektrum bozukluğu ile FOXP2, GRIN2B,KATNAL2 ve GABRA4 genleri arasında anlamlı bir ilişki saptamadık.Otizm spektrum bozukluğunun etiyopatogenezinde rol oynayan genetikrisk faktörlerinin belirlenmesi, hastalığın moleküler mekanizmalarınınanlaşılmasına ve yeni tedavi stratejilerinin geliştirilmesine önemli katkısağlayacaktır. Bu bağlamda, farklı popülasyonlarda daha fazla olgu iletüm ekzom veya tüm genom dizileme gibi kapsamlı moleküler genetikçalışmalara ihtiyaç bulunmaktadır.
Anahtar Kelime:

Investigation of the Relationship between Autism Spectrum Disorder and FOXP2, GRIN2B, KATNAL2 and GABRA4 Genes

Öz:
Introduction: Autism spectrum disorder is a genetically and phenotypically heterogeneous group. Genetic studies carried out to date have suggested that both common and rare genetic variants play a role in the etiology of this disorder. In our study, we aimed to investigate the effect of FOXP2, GRIN2B, KATNAL2 and GABRA4 gene variants in the pathogenesis of autism spectrum disorder. Method: In our prospectively planned study, all exons and exonintron junctions of FOXP2, GRIN2B, KATNAL2 and GABRA4 genes were screened by next generation sequencing analysis in 96 patients who diagnosed with autism spectrum disorder. Results: In our study, the average age was 10.1 and the male/female ratio was 75/21. Pathogenic or likely pathogenic variants were not detected in FOXP2, GRIN2B, KATNAL2 and GABRA4 genes, however, 69 intronic variants of unknown clinical significance were detected in 50 cases (52%). Among those, 26 were in the GABRA4 gene, 22 in the FOXP2 gene, 13 in the KATNAL2 gene, and 8 in the GRIN2B gene. Twenty three of these 69 variants were novel that were not previously reported in the literature. Conclusion: In our study, we could not identify a relationship between the autism spectrum disorder and FOXP2, GRIN2B, KATNAL2 and GABRA4 genes. Identifying genetic risk factors that play a role in the etiopathogenesis of autism spectrum disorder will contribute significantly to understanding the molecular mechanisms of the disease and the development of new treatment strategies. In this context, comprehensive molecular genetic studies such as whole exome or whole genome sequencing are required with higher number of cases in different populations.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Woodbury-Smith M, Paterson AD, O’Connor I, Zarrei M, Yuen RKC, Howe JL, Thompson A, Parlier M, Fernandez B, Piven J, Scherer SW, Vieland V, Szatmari P. A genome-wide linkage study of autism spectrum disorder and the broad autism phenotype in extended pedigrees. J Neurodev Disord 2018;10:20. [Crossref]
  • 2. Kalsner L, Twachtman-Bassett J, Tokarski K, Stanley C, Dumont-Mathieu T, Cotney J, Chamberlain S. Genetic testing including targeted gene panel in a diverse clinical population of children with autism spectrum disorder: Findings and implications. Mol Genet Genomic Med 2018;6:171–185. [Crossref]
  • 3. Ayhan F, Konopka G. Genomics of autism spectrum disorder: approach to therapy. F1000Res 2018;7:627. [Crossref]
  • 4. Varghese M, Keshav N, Jacot-Descombes S, Warda T, Wicinski B, Dickstein DL, Harony-Nicolas H, De Rubeis S, Drapeau E, Buxbaum JD, Hof PR. Autism spectrum disorder: neuropathology and animal models. Acta Neuropathol 2017;134:537–566. [Crossref]
  • 5. Muhle RA, Reed HE, Stratigos KA, Veenstra-VanderWeele J. The Emerging Clinical Neuroscience of Autism Spectrum Disorder: A Review. JAMA Psychiatry 2018;75:514–523. [Crossref]
  • 6. Turner LM, Stone WL, Pozdol SL, Coonrod EE. Follow-up of children with autism spectrum disorders from age 2 to age 9. Autism 2006;10:243–265. [Crossref]
  • 7. Narita A, Nagai M, Mizuno S, Ogishima S, Tamiya G, Ueki M, Sakurai R, Makino S, Obara T, Ishikuro M, Yamanaka C, Matsubara H, Kuniyoshi Y, Murakami K, Ueno F, Noda A, Kobayashi T, Kobayashi M, Usuzaki T, Ohseto H, Hozawa A, Kikuya M, Metoki H, Kure S, Kuriyama S. Clustering by phenotype and genome-wide association study in autism. Transl Psychiatry 2020;10:290. [Crossref]
  • 8. Yin J, Chun CA, Zavadenko NN, Pechatnikova NL, Naumova OY, Doddapaneni HV, Hu J, Muzny DM, Schaaf CP, Grigorenko EL. Next Generation Sequencing of 134 Children with Autism Spectrum Disorder and Regression. Genes (Basel) 2020;11:E853. [Crossref]
  • 9. Imamura A, Morimoto Y, Ono S, Kurotaki N, Kanegae S, Yamamoto N, Kinoshita H, Tsujita T, Okazaki Y, Ozawa H. Genetic and environmental factors of schizophrenia and autism spectrum disorder: insights from twin studies. J Neural Transm (Vienna) 2020;127:1501–1515. [Crossref]
  • 10. de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. Advancing the understanding of autism disease mechanisms through genetics. Nat Med 2016;22:345–361. [Crossref]
  • 11. Chahrour M, O’Roak BJ, Santini E, Samaco RC, Kleiman RJ, Manzini MC. Current perspectives in autism spectrum disorder: from genes to therapy. J Neurosci 2016;36:11402–11410. [Crossref]
  • 12. Tordjman S, Cohen D, Anderson GM, Botbol M, Canitano R, Coulon N, Roubertoux PL. Repint of “Reframing autism as a behavioral syndrome and not a specific mental disorder: Implications of genetic and phenotypic heterogeneity”. Neurosci Biobehav Rev 2018;89:132–150. [Crossref]
  • 13. Butler MG, Rafi SK, Manzardo AM. High-resolution chromosome ideogram representation of currently recognized genes for autism spectrum disorders. Int J Mol Sci 2015;16:6464–6495. [Crossref]
  • 14. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003;34:27–29. [Crossref]
  • 15. Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y, Lally E, Weiss LA, Najm J, Kutsche K, Kutsche K, Descartes M, Holt L, Braddock S, Troxell R, Kaplan L, Volkmar F, Klin A, Tsatsanis K, Harris DJ, Noens I, Pauls DL, Daly MJ, MacDonald ME, Morton CC, Quade BJ, Gusella JF. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008;82:199–207. [Crossref]
  • 16. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM, Sebat J, Wigler M, Martin CL, Ledbetter DH, Nelson SF, Cantor RM, Geschwind DH. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008;82:150–159. [Crossref]
  • 17. Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U, Endris V, Roberts W, Szatmari P, Pinto D, Bonin M, Riess A, Engels H, Sprengel R, Scherer SW, Rappold GA. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 2010;42:489–491. [Crossref]
  • 18. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, GoubranBotros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Rogé B, Héron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007;39:25–27. [Crossref]
  • 19. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Hicks J, Spence SJ, Lee AT, Puura K, Lehtimaki T, Ledbetter D, Gregersen PK, Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King MC, Skuse D, Geschwind DH, Gilliam TC, Ye K, Wigler M. Strong association of de novo copy number mutations with autism. Science 2007;316:445–449. [Crossref]
  • 20. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, Ercan-Sencicek AG, DiLullo NM, Parikshak NN, Stein JL, Walker MF, Ober GT, Teran NA, Song Y, Fishawy PE, Murtha RC, Choi M, Overton JD, Bjornson RD, Carriero NJ, Meyer KA, Bilguvar K, Mane SM, Šestan N, Lifton RP, Günel M, Roeder K, Geschwind DH, Devlin B, State MW. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012;485:237–241. [Crossref]
  • 21. Tiwary BK. The cognitive and speech genes are jointly shaped by both positive and relaxed selection in the human lineage. Genomics 2020;112:2922–2927. [Crossref]
  • 22. Vargha-Khadem F, Gadian DG, Copp A, Mishkin M. FOXP2 and the neuroanatomy of speech and language. Nat Rev Neurosci 2005;6:131–138. [Crossref]
  • 23. Carlson SL, Bohnsack JP, Morrow AL. Ethanol Regulation of Synaptic GABAA α4 Receptors Is Prevented by Protein Kinase A Activation. J Pharmacol Exp Ther 2016;357:10–16. [Crossref]
  • 24. Taylor MJ, Rosenqvist MA, Larsson H, Gillberg C, D’Onofrio BM, Lichtenstein P, Lundström S. Etiology of Autism Spectrum Disorders and Autistic Traits Over Time. JAMA Psychiatry 2020;77:936. [Crossref]
  • 25. Hu C, Chen W, Myers SJ, Yuan H, Traynelis SF. Human GRIN2B variants in neurodevelopmental disorders. J Pharmacol Sci 2016;132:115–121. [Crossref]
  • 26. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994:12:529–540. [Crossref]
  • 27. Dunleavy JEM, Okuda H, O’Connor AE, Merriner DJ, O’Donnell L, Jamsai D, Bergmann M, O’Bryan MK. Katanin-like 2 (KATNAL2) functions in multiple aspects of haploid male germ cell development in the mouse. PLoS Genet 2017;13:e1007078. [Crossref]
  • 28. Merikangas AK, Almasy L. Using the tools of genetic epidemiology to understand sex differences in neuropsychiatric disorders. Genes Brain Behav 2020;19:e12660. [Crossref]
APA YALCINTEPE S, Gorker I, Demir S, atli e, ATLI E, TOZKIR H, Süt N, OZEN Y, EKER D, Mail C, SEZGİNER GÜLER H, ZHURI D, Gürkan H (2021). Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. , 171 - 175. 10.29399/npa.27407
Chicago YALCINTEPE Sinem,Gorker Isik,Demir Selma,atli emine ikbal,ATLI ENGIN,TOZKIR HILMI,Süt Necdet,OZEN YASEMİN,EKER DAMLA,Mail Cisem,SEZGİNER GÜLER HAZAL,ZHURI DRENUSHE,Gürkan Hakan Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. (2021): 171 - 175. 10.29399/npa.27407
MLA YALCINTEPE Sinem,Gorker Isik,Demir Selma,atli emine ikbal,ATLI ENGIN,TOZKIR HILMI,Süt Necdet,OZEN YASEMİN,EKER DAMLA,Mail Cisem,SEZGİNER GÜLER HAZAL,ZHURI DRENUSHE,Gürkan Hakan Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. , 2021, ss.171 - 175. 10.29399/npa.27407
AMA YALCINTEPE S,Gorker I,Demir S,atli e,ATLI E,TOZKIR H,Süt N,OZEN Y,EKER D,Mail C,SEZGİNER GÜLER H,ZHURI D,Gürkan H Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. . 2021; 171 - 175. 10.29399/npa.27407
Vancouver YALCINTEPE S,Gorker I,Demir S,atli e,ATLI E,TOZKIR H,Süt N,OZEN Y,EKER D,Mail C,SEZGİNER GÜLER H,ZHURI D,Gürkan H Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. . 2021; 171 - 175. 10.29399/npa.27407
IEEE YALCINTEPE S,Gorker I,Demir S,atli e,ATLI E,TOZKIR H,Süt N,OZEN Y,EKER D,Mail C,SEZGİNER GÜLER H,ZHURI D,Gürkan H "Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması." , ss.171 - 175, 2021. 10.29399/npa.27407
ISNAD YALCINTEPE, Sinem vd. "Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması". (2021), 171-175. https://doi.org/10.29399/npa.27407
APA YALCINTEPE S, Gorker I, Demir S, atli e, ATLI E, TOZKIR H, Süt N, OZEN Y, EKER D, Mail C, SEZGİNER GÜLER H, ZHURI D, Gürkan H (2021). Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. Nöropsikiyatri Arşivi, 58(3), 171 - 175. 10.29399/npa.27407
Chicago YALCINTEPE Sinem,Gorker Isik,Demir Selma,atli emine ikbal,ATLI ENGIN,TOZKIR HILMI,Süt Necdet,OZEN YASEMİN,EKER DAMLA,Mail Cisem,SEZGİNER GÜLER HAZAL,ZHURI DRENUSHE,Gürkan Hakan Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. Nöropsikiyatri Arşivi 58, no.3 (2021): 171 - 175. 10.29399/npa.27407
MLA YALCINTEPE Sinem,Gorker Isik,Demir Selma,atli emine ikbal,ATLI ENGIN,TOZKIR HILMI,Süt Necdet,OZEN YASEMİN,EKER DAMLA,Mail Cisem,SEZGİNER GÜLER HAZAL,ZHURI DRENUSHE,Gürkan Hakan Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. Nöropsikiyatri Arşivi, vol.58, no.3, 2021, ss.171 - 175. 10.29399/npa.27407
AMA YALCINTEPE S,Gorker I,Demir S,atli e,ATLI E,TOZKIR H,Süt N,OZEN Y,EKER D,Mail C,SEZGİNER GÜLER H,ZHURI D,Gürkan H Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. Nöropsikiyatri Arşivi. 2021; 58(3): 171 - 175. 10.29399/npa.27407
Vancouver YALCINTEPE S,Gorker I,Demir S,atli e,ATLI E,TOZKIR H,Süt N,OZEN Y,EKER D,Mail C,SEZGİNER GÜLER H,ZHURI D,Gürkan H Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması. Nöropsikiyatri Arşivi. 2021; 58(3): 171 - 175. 10.29399/npa.27407
IEEE YALCINTEPE S,Gorker I,Demir S,atli e,ATLI E,TOZKIR H,Süt N,OZEN Y,EKER D,Mail C,SEZGİNER GÜLER H,ZHURI D,Gürkan H "Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması." Nöropsikiyatri Arşivi, 58, ss.171 - 175, 2021. 10.29399/npa.27407
ISNAD YALCINTEPE, Sinem vd. "Otizm Spektrum Bozukluğu ile FOXP2, GRIN2B, KATNAL2 ve GABRA4 Genlerinin İlişkisinin Araştırılması". Nöropsikiyatri Arşivi 58/3 (2021), 171-175. https://doi.org/10.29399/npa.27407